生育治疗后先天畸形风险增加部分由多胎妊娠介导:基于人群的队列研究
该研究基于加拿大安大略省2006至2021年有不孕诊断女性的活产和死产(≥22周)队列,发现与未治疗不孕相比,促排卵/宫腔内人工授精后任何畸形的调整相对风险为1.11,体外受精/卵胞浆内单精子注射后为1.28;多胎妊娠仅解释了超额风险的一小部分,且因畸形类型而异。
要点
- 促排卵/宫腔内人工授精后任何畸形的调整相对风险为1.11(95% CI 1.05-1.17)。
- 体外受精/卵胞浆内单精子注射后任何畸形的调整相对风险为1.28(95% CI 1.22-1.34)。
- 多胎妊娠仅介导超额风险的小部分,最高为肺动脉狭窄(促排卵/宫腔内人工授精后33.9%,体外受精/卵胞浆内单精子注射后44.4%)。
核心结论
- 多胎妊娠仅解释了生育治疗相关先天畸形风险增加的一小部分,大部分超额风险独立于多胎妊娠。
研究设计与样本
- 基于人群的队列研究,纳入加拿大安大略省2006至2021年有不孕诊断女性分娩的≥22周活产和死产,共274 893例。
主要发现
- 队列中229 932例(83.6%)为未治疗不孕,20 525例(7.5%)为促排卵/宫腔内人工授精后,24 536例(8.9%)为体外受精/卵胞浆内单精子注射后。
- 多胎率分别为2.3%、7.2%和13.3%。
- 与未治疗不孕相比,促排卵/宫腔内人工授精后任何畸形的调整相对风险为1.11(95% CI 1.05-1.17),体外受精/卵胞浆内单精子注射后为1.28(95% CI 1.22-1.34)。
- 中介分析显示多胎妊娠仅占超额风险的一小部分,比例因畸形类型而异;肺动脉狭窄的中介比例最高,促排卵/宫腔内人工授精后为33.9%,体外受精/卵胞浆内单精子注射后为44.4%。
临床怎么用
- 咨询时应告知不孕女性,生育治疗相关先天畸形风险增加的大部分不能归因于多胎妊娠。
- 继续努力减少多胎妊娠仍然重要,但需关注不孕诊断本身及治疗相关因素对畸形风险的影响。
局限性
- 使用行政健康数据,不孕状态基于计费代码可能存在错分,尤其当咨询未反映确诊诊断时。
- 存在未测量因素的残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: To what extent does multiple birth mediate the association between fertility treatment and congenital anomalies? SUMMARY ANSWER: Multiple birth explained only a modest proportion of the increased risk of congenital anomalies associated with fertility treatment, suggesting that most of the excess risk is independent of multiple birth. WHAT IS KNOWN ALREADY: Fertility treatments have been associated with an increased risk of congenital anomalies. Because fertility treatment also increases the probability of multiple birth, it remains unclear whether the observed increase in congenital anomalies is attributable to treatment itself, multiple gestation, or underlying infertility. STUDY DESIGN, SIZE, DURATION: Population-based cohort study of all live and stillbirths delivered ≥22 weeks' gestation from 2006 to 2021 among women with a history of infertility diagnosis in Ontario, Canada. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data were obtained from administrative health records routinely collected within a universal healthcare system for epidemiological surveillance. Exposure was defined as (1) infertility without fertility treatment, (2) ovulation induction (OI) or IUI, and (3) IVF or ICSI. Congenital anomalies were categorized as (1) any anomaly, (2) organ system, and (3) specific anomalies. Modified Poisson regression models generated adjusted relative risks (aRR). For statistically significant aRR > 1, causal mediation was used to decompose the total effect into direct and mediated effects to estimate proportion mediated by multiple birth. MAIN RESULTS AND THE ROLE OF CHANCE: There were 274 893 births included in the cohort, of which 229 932 (83.6%) occurred among women with infertility who did not receive fertility treatment, 20 525 (7.5%) after OI/IUI, and 24 536 (8.9%) after IVF/ICSI. Multiple birth rates were 2.3%, 7.2%, and 13.3%, respectively. Compared with infertility without treatment, the aRR of any anomaly was 1.11 (95% CI 1.05-1.17) after OI/IUI and 1.28 (95% CI 1.22-1.34) after IVF/ICSI. Mediation analyses demonstrated that multiple birth accounted for only a minority of the excess risk, although the proportion mediated varied by anomaly type. The greatest mediation was observed for pulmonary artery stenosis, where multiple birth explained 33.9% of the association after OI/IUI and 44.4% after IVF/ICSI. LIMITATIONS, REASONS FOR CAUTION: As with all studies using administrative health data, our findings are subject to potential misclassification of infertility status based on billing codes, particularly when consultations do not reflect a confirmed diagnosis, as well as residual confounding from unmeasured factors. . WIDER IMPLICATIONS OF THE FINDINGS: This study suggests that multiple birth explains only part of the increased risk of congenital anomalies observed after fertility treatment. While continued efforts to decrease multiple pregnancy remain important, future research should focus on disentangling the contribution of specific infertility diagnoses and treatment-related factors to the risk of congenital anomalies. FUNDING: This study was funded by grant MFM-146444 from the Canadian Institutes of Health Research Institute of Human Development, Child & Youth Health, Clinician-Investigator Teams in Obstetrics and Maternal-Fetal Medicine. Bailey Milne received funding for this project from the Queen's University Dean's Doctoral Award. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This document used data adapted from the Statistics Canada Postal CodeOM Conversion File, which is based on data licensed from Canada Post Corporation, and/or data adapted from the Ontario Ministry of Health Postal Code Conversion File, which contains data copied under license from ©Canada Post Corporation and Statistics Canada. Parts of this material are based on data and/or information compiled and provided by CIHI, the Ontario Ministry of Health, and the Better Outcomes Registry & Network ('BORN'), part of the Children's Hospital of Eastern Ontario. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. DISCLOSURES: The authors have nothing to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Milne BM, Velez MP, Shellenberger J, et al. Increased risk of congenital anomalies after fertility treatment is partially mediated by multiple birth: a population-based cohort study. Hum Reprod. 2026. PMID: 42533862. doi:10.1093/humrep/deag124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。